Protalix BioTherapeutics, Inc. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Debenture Agreements (1 contract)
- Exchange Agreements (3)
- Indenture Agreements (6)
- Note Agreements (7)
- Purchase Agreements (1)
- Security Agreements (1)
- Stock Agreements (4)
- Term Sheets (1)
- Underwriting Agreements (3)
- Warrant Agreements (2)
- Description of Capital Stock (Filed With SEC on February 27, 2023)
- Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,... (Filed With SEC on August 26, 2021)
- Form of Exchange Agreement, dated as of August 12, 2021 among Protalix BioTherapeutics, Inc. and the Existing Holders (Filed With SEC on August 13, 2021)
- Binding Term Sheet between Protalix Ltd. and Chiesi Farmaceutici S.p.A (Filed With SEC on May 14, 2021)
- Underwriting Agreement, dated February 11, 2021, between the Company and BofA Securities, Inc (Filed With SEC on February 16, 2021)
- Form of Stock Option Agreement (Standard) (Filed With SEC on August 10, 2020)
- Form of Stock Option Agreement (Executives) (Filed With SEC on August 10, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on March 12, 2020)
- Form of Warrant (Filed With SEC on March 12, 2020)
- Description of Capital Stock (Filed With SEC on March 12, 2020)
- Second Supplemental Indenture, dated as of November 27, 2017, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust... (Filed With SEC on December 1, 2017)
- EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of July 24, 2017 (Filed With SEC on July 25, 2017)
- NOTE PURCHASE AGREEMENT (Filed With SEC on July 25, 2017)
- FORM OF FACE OF NOTE (Filed With SEC on July 25, 2017)
- FIRST SupplementalIndenture between PROTALIXBIOTHERAPEUTICS, INC., as Issuer, ANDEACH OF THE GUARANTORS PARTY HERETO, and TheBank of New York Mellon Trust CoMPANY, N.A., as... (Filed With SEC on July 25, 2017)
- Protalix BioTherapeutics, Inc. (Company) The Bank of New York Mellon Trust Company, N.A.,as Trustee (Trustee) 4.50% Convertible Senior Notes due 2022 INDENTURE Dated as of July... (Filed With SEC on July 25, 2017)
- Dated 7 December 2016 BETWEEN PROTALIX BIOTHERAPEUTICS, INC. as the Company AND ALTSHULER SHAHAM TRUSTS LTD. as Security Trustee FORM OF SECURITY AGREEMENT/DEBENTURE UNLIMITED IN... (Filed With SEC on December 7, 2016)
- FORM OF SECURITY AGREEMENT dated as of December 7, 2016 among PROTALIX BIOTHERAPEUTICS, INC. THE GUARANTORS PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Collateral... (Filed With SEC on December 7, 2016)
- FORM OF EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of December 1, 2016 (Filed With SEC on December 7, 2016)
- FORM OF NOTE PURCHASE AGREEMENT (Filed With SEC on December 7, 2016)
- Principal Amount $40,186,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible... (Filed With SEC on December 7, 2016)
- Principal Amount $22,500,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible... (Filed With SEC on December 7, 2016)
- PROTALIX BIOTHERAPEUTICS, INC. AS ISSUER AND EACH OF THE GUARANTORS PARTY HERETO 7.50% SENIOR SECURED CONVERTIBLE NOTESDUE 2021 INDENTURE DATED AS OF DECEMBER 7, 2016 THE BANK OF... (Filed With SEC on December 7, 2016)
- ProtalixBioTherapeutics, Inc. $60,000,0004.50% Convertible Notes Due 2018 PurchaseAgreement (Filed With SEC on September 18, 2013)
- [FACE OF NOTE] (Filed With SEC on September 18, 2013)
- ProtalixBioTherapeutics, Inc. (Company) The Bankof New York Mellon Trust Company, N.A. (Trustee) 4.50%Convertible Senior Notes due 2018 INDENTURE Datedas of September 18, 2013 (Filed With SEC on September 18, 2013)
- Protalix BioTherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on February 16, 2012)
- Underwriting Agreement (Filed With SEC on October 25, 2007)
- EX-4.1 Form of Warrant (Filed With SEC on January 8, 2007)